HHS Purchases Additional Smallpox Vaccine for SNS
The U.S. Department of Health and Human Services (HHS) announced this week that they will be purchasing a smallpox vaccine, called ACAM2000, to build and replenish vaccine stored in the Strategic National Stockpile (SNS) over the next decade.
Under the agreement the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), which oversees the SNS, will award approximately $170 million to Emergent BioSolutions of Gaithersburg, Maryland, for the purchase this year. ASPR can purchase additional vaccine over the next 10 years, with a target of $2 billion in procurement and surge options for up to a total of nearly $2.8 billion.
ACAM2000 was licensed by the The U.S. Food and Drug Administration in 2007 for people at high risk for smallpox infection. To be cost-efficient, the SNS rotates stored smallpox vaccine to DoD for military members deploying to high-risk areas, and HHS then replenishes the vaccine stockpile.